(CSTM) Constellium - Overview
Sector: Basic Materials | Industry: Aluminum | Exchange: NYSE (USA) | Market Cap: 4.803m USD | Total Return: 176.1% in 12m
Avg Turnover: 72.9M
EPS Trend: -17.1%
Qual. Beats: 2
Rev. Trend: -37.1%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Supp Ema20, Rs Leader, Idiosyncratic Leader, Tailwind, Pullback 52w, Confidence
Constellium SE is a global manufacturer specializing in rolled and extruded aluminum products across three primary segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The company’s portfolio includes high-value components such as beverage canstock, aerospace plates, and automotive crash management systems. Headquartered in Paris, it maintains a diverse geographic footprint with manufacturing and sales operations across Europe, North America, and Asia.
The aluminum industry is characterized by its cyclical nature and high capital intensity, where profitability is often influenced by energy costs and regional premiums on raw materials. Aluminum’s high strength-to-weight ratio makes it a critical material for the automotive and aerospace sectors as manufacturers seek to improve fuel efficiency through vehicle lightweighting. Constellium operates a vertically integrated model, utilizing both primary metal and recycled scrap to supply specialized downstream applications.
Investors may find additional financial metrics and historical performance data on ValueRay to further their due diligence. The company serves a broad range of end-markets, reducing its reliance on any single industrial cycle while maintaining a focus on technical R&D and surface treatment services.
- Increased demand for aluminum beverage cans drives packaging segment revenue growth
- Rising aerospace production rates boost high-margin plate and sheet product sales
- Fluctuating energy costs and aluminum premiums impact overall manufacturing profit margins
- Automotive lightweighting trends accelerate demand for structural components and body sheets
- Global economic slowdown reduces industrial extrusion orders and commercial transportation volumes
| Net Income: 373.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 4.79 > 1.0 |
| NWC/Revenue: 10.89% < 20% (prev 5.99%; Δ 4.90% < -1%) |
| CFO/TA 0.09 > 3% & CFO 512.6m > Net Income 373.9m |
| Net Debt (1.95b) to EBITDA (886.7m): 2.20 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (140.1m) vs 12m ago -2.78% < -2% |
| Gross Margin: 15.06% > 18% (prev 0.14%; Δ 1.49k% > 0.5%) |
| Asset Turnover: 138.9% > 50% (prev 138.2%; Δ 0.67% > 0%) |
| Interest Coverage Ratio: 6.51 > 6 (EBITDA TTM 886.7m / Interest Expense TTM 92.1m) |
| A: 0.14 (Total Current Assets 2.95b - Total Current Liabilities 2.12b) / Total Assets 5.84b |
| B: 0.09 (Retained Earnings 529.0m / Total Assets 5.84b) |
| C: 0.11 (EBIT TTM 600.0m / Avg Total Assets 5.51b) |
| D: 0.12 (Book Value of Equity 572.0m / Total Liabilities 4.71b) |
| Altman-Z'' = 2.09 = BBB |
| DSRI: 1.15 (Receivables 1.00b/818.0m, Revenue 7.65b/7.14b) |
| GMI: 0.93 (GM 15.06% / 14.03%) |
| AQI: 0.69 (AQ_t 0.06 / AQ_t-1 0.09) |
| SGI: 1.07 (Revenue 7.65b / 7.14b) |
| TATA: -0.02 (NI 373.9m - CFO 512.6m) / TA 5.84b) |
| Beneish M = -3.13 (Cap -4..+1) = AA |
As of May 28, 2026, the stock is trading at USD 33.96 with a total of 4,965,341 shares traded.
Over the past week, the price has changed by +8.71%,
over one month by +8.88%,
over three months by +36.44% and
over the past year by +176.10%.
Constellium has received a consensus analysts rating of 4.60. Therefore, it is recommended to buy CSTM.
- StrongBuy: 4
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 37.4 | 10.2% |
P/E Trailing = 11.2716
P/E Forward = 8.1566
P/S = 0.5378
P/B = 4.0444
P/EG = 0.3974
Revenue TTM = 7.65b USD
EBIT TTM = 600.0m USD
EBITDA TTM = 886.7m USD
Long Term Debt = 1.94b USD (from longTermDebt, last quarter)
Short Term Debt = 35.0m USD (from shortTermDebt, last quarter)
Debt = 2.09b USD (from shortLongTermDebtTotal, last quarter) + Leases 120.0m
Net Debt = 1.95b USD (calculated: Debt 2.09b - CCE 143.0m)
Enterprise Value = 6.75b USD (4.80b + Debt 2.09b - CCE 143.0m)
Interest Coverage Ratio = 6.51 (Ebit TTM 600.0m / Interest Expense TTM 92.1m)
EV/FCF = 38.60x (Enterprise Value 6.75b / FCF TTM 174.9m)
FCF Yield = 2.59% (FCF TTM 174.9m / Enterprise Value 6.75b)
FCF Margin = 2.29% (FCF TTM 174.9m / Revenue TTM 7.65b)
Net Margin = 4.89% (Net Income TTM 373.9m / Revenue TTM 7.65b)
Gross Margin = 15.06% ((Revenue TTM 7.65b - Cost of Revenue TTM 6.50b) / Revenue TTM)
Gross Margin QoQ = 17.07% (prev 15.77%)
Tobins Q-Ratio = 1.16 (Enterprise Value 6.75b / Total Assets 5.84b)
Interest Expense / Debt = 4.40% (Interest Expense 92.1m / Debt 2.09b)
Taxrate = 27.94% (66.0m / 236.3m)
NOPAT = 432.4m (EBIT 600.0m * (1 - 27.94%))
Current Ratio = 1.39 (Total Current Assets 2.95b / Total Current Liabilities 2.12b)
Debt / Equity = 1.87 (Debt 2.09b / totalStockholderEquity, last quarter 1.12b)
Debt / EBITDA = 2.20 (Net Debt 1.95b / EBITDA 886.7m)
Debt / FCF = 11.15 (Net Debt 1.95b / FCF TTM 174.9m)
Total Stockholder Equity = 923.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.79% (Net Income 373.9m / Total Assets 5.84b)
RoE = 40.47% (Net Income TTM 373.9m / Total Stockholder Equity 923.9m)
RoCE = 20.97% (EBIT 600.0m / Capital Employed (Equity 923.9m + L.T.Debt 1.94b))
RoIC = 11.55% (NOPAT 432.4m / Invested Capital 3.75b)
WACC = 8.20% (E(4.80b)/V(6.90b) * Re(10.39%) + D(2.09b)/V(6.90b) * Rd(4.40%) * (1-Tc(0.28)))
Discount Rate = 10.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -85.40 | Cagr: -2.77%
[DCF] Terminal Value 75.44% ; FCFF base≈174.9m ; Y1≈175.7m ; Y5≈186.1m
[DCF] Fair Price = 6.94 (EV 2.89b - Net Debt 1.95b = Equity 944.2m / Shares 136.2m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: -17.08 | EPS CAGR: -10.70% | SUE: 1.88 | # QB: 2
Revenue Correlation: -37.13 | Revenue CAGR: -1.98% | SUE: 0.26 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.81 | Chg30d=+69.89% | Revisions=+0% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.54 | Chg30d=+34.76% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=3.02 | Chg30d=+75.10% | Revisions=+25% | GrowthEPS=+85.8% | GrowthRev=+24.0%
EPS next Year (2027-12-31): EPS=2.53 | Chg30d=+34.34% | Revisions=+20% | GrowthEPS=-15.2% | GrowthRev=+2.6%
[Analyst] Revisions Ratio: +25%